MR Capeding, NH Tran, SRS Hadinegoro… - The Lancet, 2014 - thelancet.com
Background An estimated 100 million people have symptomatic dengue infection every
year. This is the first report of a phase 3 vaccine efficacy trial of a candidate dengue vaccine …